Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort Study

Florence Dalenc (1) , Frédérique Penault-Llorca (2, 3) , Monique Cohen (4) , Gilles Houvenaeghel (5) , Jean-Marc Piat , Philippe Liegeois , Laurent Puyuelo , Jean-Philippe Suchaud , Mohammed Zouai , Magali Lacroix-Triki (6) , Nina Radosevic-Robin (7) , Chahinez Benkanoun , Hanane Attar-Rabia , Marie-Pierre Chauvet , Joseph Gligorov (8) , Yazid Belkacemi (9)

1 Departement /u563 : Oncogenèse, Signalisation et Innovation thérapeutique
2 UNICANCER/CJP - Centre Jean Perrin [Clermont-Ferrand]
3 IMoST - Imagerie Moléculaire et Stratégies Théranostiques
4 La Casamance
5 IPC - Institut Paoli-Calmettes
6 Département de Biologie et de Pathologie
7 ERTICa - Equipe de recherche sur les traitements individualisés des cancers
8 CHU Tenon [AP-HP]
9 Service de radiothérapie [Mondor]

Most breast cancer (BC) tumors ≤10 mm have an excellent prognosis. The subgroups with a higher risk for distant recurrence requiring adjuvant systemic therapy are not precisely defined in current international guidelines.

Mots clés: Adjuvant treatment; Breast cancer subtypes; Conservative surgery; Endocrine therapy; Radiotherapy

Domaines: Cancer

Florence Dalenc, Frédérique Penault-Llorca, Monique Cohen, Gilles Houvenaeghel, Jean-Marc Piat, et al.. Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort Study. Clinical Breast Cancer, 2017, 17 (2), pp.107 - 116. ⟨10.1016/j.clbc.2016.08.007⟩. ⟨hal-01675191⟩